组织学疾病活动度评估在溃疡性结肠炎中的新兴作用
本文综述了溃疡性结肠炎组织学评分指标的最新文献,指出组织学能准确预测临床复发、住院、皮质类固醇使用和异型增生,且可能比内镜更具预测性。文章推荐根据最严重受累活检碎片进行总体评估,报告隐窝结构扭曲、基底浆细胞增多和中性粒细胞活动,并提出基于疾病慢性化/活动度和基底浆细胞增多的5分类系统。
要点
- 组织学可准确预测溃疡性结肠炎的临床复发、住院、皮质类固醇使用和异型增生。
- 显微镜下疾病活动可在无临床或内镜活动时持续存在,组织学可能是理想的炎症标志物。
- 推荐根据最严重受累活检碎片进行总体评估,并报告隐窝结构扭曲、基底浆细胞增多和中性粒细胞活动。
核心结论
- 组织学疾病活动虽很少用于测量炎症和指导治疗,但可预测溃疡性结肠炎的重要临床结局。
- 需要随机对照试验来确定组织学是否应作为治疗目标。
研究设计与样本
- 本综述总结了关于溃疡性结肠炎组织学评分指标的最新文献,并为消化内科医生解读组织学数据提供实用指导。
主要发现
- 大量证据表明组织学能准确预测临床复发、住院、皮质类固醇使用和异型增生。
- 与内镜相比,研究结果提示组织学可能对这些结局更具预测性。
- 显微镜下疾病活动可在无临床或内镜疾病活动时持续存在,因此组织学可能是理想的炎症标志物。
关键数值与推荐
- 推荐根据最严重受累的活检碎片确定疾病严重度的总体评估。
- 应报告隐窝结构扭曲、基底浆细胞增多和中性粒细胞活动。
- 提出基于疾病慢性化/活动度和基底浆细胞增多的5分类系统。
- 目前尚不需要报告黏膜嗜酸性粒细胞增多程度或使用经过验证的评分系统,尽管后者可能有助于确定治疗反应。
- 需要组织学缓解和反应的标准化定义以及活检取材方案来指导临床决策。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需要随机对照试验来确定组织学是否应作为治疗目标。
- 需要组织学缓解和反应的标准化定义以及活检取材方案来指导临床决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Assessment of disease activity is essential for developing and determining appropriate therapy in patients with ulcerative colitis (UC). Validated clinical and endoscopic scoring systems have been established to accurately define disease activity. Clinical and endoscopic treatment targets have also been proposed, with gastroenterologists encouraged to optimize medical therapy to achieve these targets. Recently, histology has been recognized as an important prognostic factor and potential treatment target in patients with UC. METHODS: This review summarizes the recent literature regarding histologic scoring indices in UC and offers practical guidance to gastroenterologists on how to interpret histologic data. RESULTS: Substantial evidence indicates that histology accurately predicts clinical relapse, hospitalization, corticosteroid use, and development of dysplasia. Furthermore, compared with endoscopy, findings suggest that histology may be more predictive of these outcomes. Because microscopic disease activity can persist in the absence of clinical or endoscopic disease activity, histology may be the ideal marker of inflammation. Standardized definitions of histologic response and remission and a biopsy procurement protocol are needed to guide clinical decision making. It is recommended that overall assessment of disease severity be determined according to the worst affected biopsy fragment. Crypt architectural distortion, basal plasmacytosis, and neutrophilic activity should be reported. A 5-category classification system based on disease chronicity/activity and basal plasmacytosis is proposed. It is not yet necessary to report on the degree of mucosal eosinophilia or use a validated scoring system, although the latter may aid in determining therapeutic response. CONCLUSIONS: Although rarely used to measure inflammation and guide therapy, histologic disease activity is predictive of important clinical outcomes in UC. Randomized controlled trials are needed to determine whether histology should function as a treatment target.
引用
- Pai RK, Jairath V, Vande Casteele N, et al. The emerging role of histologic disease activity assessment in ulcerative colitis. Gastrointest Endosc. 2018. PMID: 30142351. doi:10.1016/j.gie.2018.08.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。